Jennifer Kelly, APRN
Family · Columbus, OHNPI 1881216463
Payments from drug & device makers
Across 46 payments — averaging $98.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Axonics, Inc.$1K
- BETA Bionics, Inc.$146
- Bluewind Medical$136
- Dexcom, Inc.$125
- Sequel Med Tech, LLC$112
What the payments were for
- Travel & lodging$2,67459%
- Food & beverage$1,78839%
- Education$681%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 27 | $2,608 |
| Axonics, Inc. | 15 | $1,402 |
| BETA Bionics, Inc. | 1 | $146 |
| Bluewind Medical | 1 | $136 |
| Dexcom, Inc. | 1 | $125 |
| Sequel Med Tech, LLC | 1 | $112 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$1,902
- Axonics$952
- iLet Bionic Pancreas$438
- Bulkamid$227
- REVI$136
- DEXCOM G6 TRANSMITTER$125
- TWIIST$112
How this compares
$4,529 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 534 | $349,011 |
| GemtesaVibegron | 231 | $151,868 |
| Mirabegron ErMirabegron | 39 | $20,503 |
| Solifenacin Succinate | 220 | $12,619 |
| Estradiol | 123 | $7,768 |
| Methenamine Hippurate | 115 | $6,755 |
| Oxybutynin Chloride ErOxybutynin Chloride | 326 | $6,593 |
| Trospium Chloride ErTrospium Chloride | 59 | $5,475 |
| Tamsulosin Hcl | 352 | $4,957 |
| Trospium Chloride | 84 | $4,434 |
| Tolterodine Tartrate ErTolterodine Tartrate | 25 | $3,762 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 100 | $1,563 |
| Finasteride | 72 | $941 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 66 | $813 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 12 | $648 |
Paid to pharmacies, not to this prescriber.
Other family in Columbus
- Christina GastColumbus$66K
- Beth LoessinColumbus$34K
- Mary HurleyColumbus$15K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.